415 research outputs found
Automated analysis of atrial late gadolinium enhancement imaging that correlates with endocardial voltage and clinical outcomes: A 2-center study
This work was supported by the British Heart Foundation PG/10/37/28347, RG/10/11/28457, NIHR Biomedical Research Centre funding, and the ElectroCardioMaths Programme of the Imperial BHF Centre of Research Excellence
Mind the gap: quantification of incomplete ablation patterns after pulmonary vein isolation using minimum path search
Pulmonary vein isolation (PVI) is a common procedure for the treatment of
atrial fibrillation (AF). A successful isolation produces a continuous lesion
(scar) completely encircling the veins that stops activation waves from
propagating to the atrial body. Unfortunately, the encircling lesion is often
incomplete, becoming a combination of scar and gaps of healthy tissue. These
gaps are potential causes of AF recurrence, which requires a redo of the
isolation procedure. Late-gadolinium enhanced cardiac magnetic resonance
(LGE-CMR) is a non-invasive method that may also be used to detect gaps, but it
is currently a time-consuming process, prone to high inter-observer
variability. In this paper, we present a method to semi-automatically identify
and quantify ablation gaps. Gap quantification is performed through minimum
path search in a graph where every node is a scar patch and the edges are the
geodesic distances between patches. We propose the Relative Gap Measure (RGM)
to estimate the percentage of gap around a vein, which is defined as the ratio
of the overall gap length and the total length of the path that encircles the
vein. Additionally, an advanced version of the RGM has been developed to
integrate gap quantification estimates from different scar segmentation
techniques into a single figure-of-merit. Population-based statistical and
regional analysis of gap distribution was performed using a standardised
parcellation of the left atrium. We have evaluated our method on synthetic and
clinical data from 50 AF patients who underwent PVI with radiofrequency
ablation. The population-based analysis concluded that the left superior PV is
more prone to lesion gaps while the left inferior PV tends to have less gaps
(p<0.05 in both cases), in the processed data. This type of information can be
very useful for the optimization and objective assessment of PVI interventions
Medical Image Analysis on Left Atrial LGE MRI for Atrial Fibrillation Studies: A Review
Late gadolinium enhancement magnetic resonance imaging (LGE MRI) is commonly
used to visualize and quantify left atrial (LA) scars. The position and extent
of scars provide important information of the pathophysiology and progression
of atrial fibrillation (AF). Hence, LA scar segmentation and quantification
from LGE MRI can be useful in computer-assisted diagnosis and treatment
stratification of AF patients. Since manual delineation can be time-consuming
and subject to intra- and inter-expert variability, automating this computing
is highly desired, which nevertheless is still challenging and
under-researched.
This paper aims to provide a systematic review on computing methods for LA
cavity, wall, scar and ablation gap segmentation and quantification from LGE
MRI, and the related literature for AF studies. Specifically, we first
summarize AF-related imaging techniques, particularly LGE MRI. Then, we review
the methodologies of the four computing tasks in detail, and summarize the
validation strategies applied in each task. Finally, the possible future
developments are outlined, with a brief survey on the potential clinical
applications of the aforementioned methods. The review shows that the research
into this topic is still in early stages. Although several methods have been
proposed, especially for LA segmentation, there is still large scope for
further algorithmic developments due to performance issues related to the high
variability of enhancement appearance and differences in image acquisition.Comment: 23 page
Advances in imaging for atrial fibrillation ablation.
Over the last fifteen years, our understanding of the pathophysiology of atrial fibrillation (AF) has paved the way for ablation to be utilized as an effective treatment option. With the aim of gaining more detailed anatomical representation, advances have been made using various imaging modalities, both before and during the ablation procedure, in planning and execution. Options have flourished from procedural fluoroscopy, electroanatomic mapping systems, preprocedural computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, and combinations of these technologies. Exciting work is underway in an effort to allow the electrophysiologist to assess scar formation in real time. One advantage would be to lessen the learning curve for what are very complex procedures. The hope of these developments is to improve the likelihood of a successful ablation procedure and to allow more patients access to this treatment
Cardiovascular magnetic resonance guided electrophysiology studies
Catheter ablation is a first line treatment for many cardiac arrhythmias and is generally performed under x-ray fluoroscopy guidance. However, current techniques for ablating complex arrhythmias such as atrial fibrillation and ventricular tachycardia are associated with suboptimal success rates and prolonged radiation exposure. Pre-procedure 3D CMR has improved understanding of the anatomic basis of complex arrhythmias and is being used for planning and guidance of ablation procedures. A particular strength of CMR compared to other imaging modalities is the ability to visualize ablation lesions. Post-procedure CMR is now being applied to assess ablation lesion location and permanence with the goal of indentifying factors leading to procedure success and failure. In the future, intra-procedure real-time CMR, together with the ability to image complex 3-D arrhythmogenic anatomy and target additional ablation to regions of incomplete lesion formation, may allow for more successful treatment of even complex arrhythmias without exposure to ionizing radiation. Development of clinical grade CMR compatible electrophysiology devices is required to transition intra-procedure CMR from pre-clinical studies to more routine use in patients
Interventional techniques in the management of persistent atrial fibrillation
Atrial fibrillation (AF) is a common cardiac rhythm problem experienced by patients and comprises an increasing demand on healthcare systems. AF is characterised by advanced neurohormonal remodelling in the atria resulting in dilation and variable degree of atrial fibrosis that can be measured by imaging techniques with difficulty in developing methods of identifying and quantifying left atrial (LA) fibrosis. LA fibrosis can be estimated by measuring LA scar using non-invasive imaging methods such as strain imaging in advanced echocardiography and in cardiac magnetic resonance (CMR) imaging. Achieving rhythm control strategy utilising catheter ablation (CA) has shown to be advantageous in improving quality of life (QOL) in patients with paroxysmal AF. The most effective method in management of AF has remained elusive in non-paroxysmal AF. Thoracoscopic surgical ablation (TSA) has been developed over the last decade by experienced surgeons with some promising early results but has not been investigated in long-standing persistent AF (LSPAF).
I have attempted to answer some of the relevant questions that have remained in management of LSPAF by conducting a multicentre randomised control trial comparing efficacy between CA and TSA (CASA-AF RCT) and improvements in quality of life indices. In a sub-study, I measured LA volumes using echocardiography and CMR to determine reverse remodelling and LA function using tissue Doppler imaging and strain imaging to predict AF recurrence. In a CMR sub-study, a novel automatic LA segmentation algorithm was used to
quantify LA fibrosis before and after ablation. I was able to quantify the response of the autonomic nervous system to targeted ganglionic plexi (GP) ablation as part of TSA compared to CA by measuring heart rate variability. I am hopeful that the knowledge gained from this thesis will help with an appropriate
selection that will improve the management of patients with LSPAF.Open Acces
Ablation Lesion Assessment with MRI
Late gadolinium enhancement (LGE) MRI is capable of detecting not only native cardiac fibrosis, but also ablation-induced scarring. Thus, it offers the unique opportunity to assess ablation lesions non-invasively. In the atrium, LGE-MRI has been shown to accurately detect and localise gaps in ablation lines. With a negative predictive value close to 100% it can reliably rule out pulmonary vein reconnection non-invasively and thus may avoid unnecessary invasive repeat procedures where a pulmonary vein isolation only approach is pursued. Even LGE-MRI-guided repeat pulmonary vein isolation has been demonstrated to be feasible as a standalone approach. LGE-MRI-based lesion assessment may also be of value to evaluate the efficacy of ventricular ablation. In this respect, the elimination of LGE-MRI-detected arrhythmogenic substrate may serve as a potential endpoint, but validation in clinical studies is lacking. Despite holding great promise, the widespread use of LGE-MRI is still limited by the absence of standardised protocols for image acquisition and post-processing. In particular, reproducibility across different centres is impeded by inconsistent thresholds and internal references to define fibrosis. Thus, uniform methodological and analytical standards are warranted to foster a broader implementation in clinical practice
Late gadolinium enhancementâMRI determines definite lesion formation most accurately at 3 months post ablation compared to later time points
Aims: Neither the long-term development of ablation lesions nor the capability of late gadolinium enhancement (LGE)-MRI to detect ablation-induced fibrosis at late stages of scar formation have been defined. We sought to assess the development of atrial ablation lesions over time using LGE-MRI and invasive electroanatomical mapping (EAM).
Methods and results: Ablation lesions and total atrial fibrosis were assessed in serial LGE-MRI scans 3 months and >12 months post pulmonary vein (PV) isolation. High-density EAM performed in subsequent repeat ablation procedures served as a reference. Serial LGE-MRI of 22 patients were analyzed retrospectively. The PV encircling ablation lines displayed an average LGE, indicative of ablation-induced fibrosis, of 91.7% ± 7.0% of the circumference at 3 months, but only 62.8% ± 25.0% at a median of 28 months post ablation (p 12 months post ablation. Accordingly, the agreement with EAM regarding detection of ablation-induced fibrosis and functional gaps was good for the LGE-MRI at 3 months (Îș .74; p < .0001), but only weak for the LGE-MRI at 28 months post-ablation (Îș .29; p < .0001).
Conclusion: While non-invasive lesion assessment with LGE-MRI 3 months post ablation provides accurate guidance for future redo-procedures, detectability of atrial ablation lesions appears to decrease over time. Thus, it should be considered to perform LGE-MRI 3 months post-ablation rather than at later time-points > 12 months post ablation, like for example, prior to a planned redo-ablation procedure
- âŠ